Mutants of Pseudornonas aeruginosa PAC I were isolated which, unlike the wildtype, could utilize phenylacetamide as a nitrogen source for growth. One group of these mutants had lost the ability to grow on acetamide; the second group grew slowly on acetamide. Group I included 12 mutants isolated from the magnoconstitutive butyramide-utilizing strain PAC35 I and one mutant isolated from the valeramide-utilizing mutant ~~~3 6 0 .
S U M M A R Y
Mutants of Pseudornonas aeruginosa PAC I were isolated which, unlike the wildtype, could utilize phenylacetamide as a nitrogen source for growth. One group of these mutants had lost the ability to grow on acetamide; the second group grew slowly on acetamide. Group I included 12 mutants isolated from the magnoconstitutive butyramide-utilizing strain PAC35 I and one mutant isolated from the valeramide-utilizing mutant ~~~3 6 0 .
Group T Ph amidases hydrolysed phenylacetamide, butyramide and valeramide but not acetamide or forniamide. Group I1 Ph mutants produced thermolabile amidases which attacked the same range of arnide substrates but in addition had weak activity towards acetamide. Three group I1 mutants were derived from a constitutive butyramide-regulator mutant PACI 28: one from ~~~3 6 0 and one from ~~~3 2 6 , a mutant producing a defective amidase.
I N T R O D U C T I O N
Pseudomorzas aeruginosa wild-type amidase has a narrow range of substrates, hydrolysing aliphatic amides containing I-, 2-or 3-carbon atoms with only trace activity on the 4-carbon amide, butyramide. Acetamide and propionaniide are good inducers of the enzyme and the wild-type strain is able to utilize these two amides as growth substrates. We have previously shown that mutations in either the amidase structural gene or the regulator gene, or in both genes, enable growth in a minimal salt medium with various other amides providing either the carbon or the nitrogen source for growth. Brown, Brown & Clarke (1969) described mutants able to utilize butyramide and valeramide which produced amidases with altered substrate specificities. Brown & Clarke ( I 972) isolated mutants which utilized the Nsubstituted amide acetanilide (N-phenylacetamide) as carbon source. The amidase produced by one of these strains differed from the wild-type enzyme by a single amino acid substitution.
As part of an investigation of directed evolution at the molecular level the substrate range of this aliphatic amidase was extended to longer chain amides and attempts were made to isolate mutants producing amidases capable of hydrolysing amides with an aromatic ring attached to the amide side chain, e.g. phenylacetamide. Various types of mutants were available as potential parental strains. Constitutive strains were thought to be advantageous since they would require only the appropriate structural gene mutation to allow hydrolysis of phenylacetamide. The most promising of these was the group of constitutive mutants of the CB series isolated by Brown & Clarke (1970) which were resistant to repression by amide analogues. The acetanilide-utilizing mutants had been isolated from a regulator mutant Organisms. The parent strain was Pseudomonas aeruginosa PAC I (8602). All strains used and isolated in this study are listed in Table I . The symbols for genotype and phenotype are in accordance with the system proposed by Demerec, Adelburg, Clark & Hartman (I 966). The numbering of the strains in our collection is now in accordance with this system and is also compatible with systems used for other collections of Pseudomonas mutants (cf. Holloway, 1969) . We have previously used series numbers for various classes of mutants and these are included for both old and new isolates to assist in identification and discussion of mutant properties.
Media. Plate growth tests. Strains were grown overnight in 5 ml of nutrient broth; a loopful of culture was diluted in 2 ml of dilution buffer and one loopful spread as a patch inoculum on the amide selective medium. Each plate was inoculated with six cultures and appropriate control cultures were included in each series of tests. The plates were incubated at 37 "C for 3 days.
Mutagenic treatment. Methods for mutagenesis by ultraviolet (u.v.) irradiation, treatment with N-methyl-"nitro-N-nitrosoguanidine (NMG) and ethylmethane sulphonate (EMS) were as described by Brammar, Clarke & Skinner (1967) but for some experiments the chemical mutagens were applied to paper discs set in the centre of plates spread with the culture to be treated.
Enzyme assays. The acyl transferase assay (Brammar & Clarke, 1964) could be used for all the amides except for formamide which reacts spontaneously with hydroxylamine at too high a rate to be used. The physiologically important reaction is amide hydrolysis and for the amides with large side-chains the insolubility in water of the corresponding acids limits the methods available. Amide hydrolysis was measured by estimating the ammonia released by the ninhydrin method as described by Brown et al. (1969) . For both transferase and hydrolase activity measurements the amides were used at a concentration of 0.2 M except for phenylacetamide which was limited by solubility to 0.05 M.
Enzyme puriJication. The amidases produced by the phenylacetamide-utilizing mutants were purified by methods based on those used by Brown et al. (1969) and Brown & Clarke (1972) . The heat treatment step was omitted and 5% (vlv) glycerol and I mM-dithiothreitol was added to the extract and to all the buffers to protect the labile amidases produced by Phv2, PhFI and PhAr (J. L. Phenylacetam ide-ut ilizing mutants of P. aeruginosa 163 Starch gel electrophoresis. The methods used were those described by Brown et a/. (1969) . Immunodiflusion. Experiments were carried out in agar gels as described by Brown et al. (i969) , but using 0.9 N-NaCl instead of barbitone buffer to prepare the gels.
Reagents. Benzamide and phenylacetamide were obtained from British Drug Houses Ltd, Godalming, Surrey, and recrystallized twice from distilled water. Hexanoamide, octanoamide and phenylpropionamide were prepared by ammoniolysis of the acid chlorides, and mandelamide from methylmandelate by Mr P. D. Laverack. Other amides and reagents used in enzyme assays were as described by Brown et al. (1969) .
R E S U L T S
Pseudomonas aeruginosa is unable to metabolize phenylacetate (Stanier, Palleroni & Doudoroff, 1966) so that the media used for isolation of Ph mutants contained phenylacetamide as the nitrogen source and succinate or pyruvate as the carbon source. Phenylacetamide is neither a substrate nor inducer of amidase synthesis in the wild-type strain, and Brown (I 969) found that it repressed amidase synthesis by the constitutive mutant PACI I I.
None of the mutants selected as potential strains for the isolation of phenylacetamide mutants were able to grow on succinate + phenylacetamide (S/Ph) minimal agar. Mutagenic treatments used included U.V. irradiation, and the chemical mutagens EMS and NMG. The bacteria were usually treated with the chemical mutagen, centrifuged, washed and grown in broth for several hours before plating on the selective media. For some experiments broth cultures were washed and plated on S/Ph minimal agar and a paper disc soaked in the mutagen was placed in the centre of the plate.
Colonies of phenylacetamide-utilizing mutants appeared after 3 to 7 days of incubation at 37 'C from some of the strains. As had been expected, none were obtained from the wildtype strain PAci. Two acetamide-negative mutants P A C~O~ and PAC322, both of which had the inducible wild-type regulator gene, were subjected to mutagenic treatment but no Ph mutants were obtained. None of the experiments with the constitutive strain PACI I I, or the constitutive mutant resistant to catabolite repression, P A C I~~, were successful in producing phenylacetamide mutants. Most of the mutants were obtained from strain PAC35I. This was derived from strain PAC[ I I and has a further single mutation, in the structural gene, which results in the production of the mutant B amidase . Three mutants were obtained from strain P A C I~~. This is a constitutive strain, resistant to repression by butyramide and other amide analogues, producing the wild-type A amidase. Two mutants were obtained from strain ~~~3 6 0 , a constitutive valeramide-utilizing mutant derived from P A C~~I by a second mutation in the amidase structural gene. Another mutant was obtained from ~~~3 2 6 which is an acetamide-negative mutant derived from the constitutive, catabolite repression-resistant strain PAC 142. We have previously used series numbers to identify the various groups of amidase mutants and we have continued to do this for the phenylacetamide mutants. The series number provides a convenient and simple reference to the parentage of each mutant and was useful in the preliminary grouping of the enzymes produced. Table I lists the strains used and Fig. 5 outlines the routes by which the phenylacetamide-utilizing mutants which were isolated. to ~~~3 8 7 derived from strain P A C~~I ; ~~~3 8 8 , 3 8 9 from ~~~3 6 0 ; P A C~~I from ~~~3 2 6 ; -i-Genotype abbreviations : amiR, amidase regulator gene ; amiE, amidase structural gene.
PAC392 to PAC394 from PAC128.
Phenotype abbreviations: Ind, inducible; Con, constitutive, But-r, resistant to butyramide repression; Crp-r, resistant to catabolite repression; Anii A, amidase A; Arni B, amidase B; Ami V, amidase V; Anii Ph, amidase Ph; Ami-d, defective amidase. (F series) (Brammar et al. 1967) . Formamide is a poor inducer for the wild-type strain but is hydrolysed by the A amidase at a reasonable rate and can thus be used as a nitrogen source by the c and F strains. Mutant P A C~~O is constitutive and produces a V-type enzyme which enables it to grow on valeramide but it cannot grow on S/F plates because the V amidases to not hydrolyse formamide. Brown et al. (1969) found that some of the v mutants were also unable to grow on acetamide.
The 18 Ph mutants were constitutive but none was able to grow on S/F plates ( Table 2 ). The PhB group derived from P A C~~I were all acetamide-negative but some of the other mutants, Phv2, PhAI and the PhF group, produced slight growth on acetamide plates. The 12 PhB mutants, although obtained by a variety of mutagenic treatments, were similar in growth range so that only P h~3 is listed in Table 2 . The amide growth substrates available to all the Ph group extended from the 4-carbon amide butyramide and included valeramide, hexoanoamide and octanoamide as well as phenylacetamide. Compared with the very limited range of amides available for growth of the wild-type strain this group of mutants has acquired the ability to utilize a much wider range of amides. The Ph mutants grew well on plates containing I % (w/v) sodium succinate with either 0.1 or 0.2% (w/v) phenylacetamide.
With 0.3 y o (w/v) phenylacetamide there was no growth even when (NH,),SO, (0.1 yo w/v) had been added as a nitrogen source. Growth inhibition appeared to be due to the amide itself since 0.3~; phenylacetate did not affect growth. In liquid minimal salt medium with I y:, (w/v) sodium succinate as carbon source the mean generation time of strain P h~2 with 0.1 7; phenylacetamide was 120 min; for 0.2 "/o phenylacetamide it was 210 min; at concentrations of phenylacetamide > 0 . 2 5 ' ;~~ there was no measurable growth during 20 h.
Amidase actiiTities of bacterial suspensions
Cultures were grown overnight in pyruvate medium, washed and resuspended in 0.1 M-trk buffer, pH 7-2, at a density which would give values for the enzyme assays within the standard range. Table 3 gives the relative rates of hydrolysis of formamide, acetamide, propionamide, butyramide, valeramide and phenylacetamide with butyramide assigned an arbitrary value of 100. Also included are values for the specific activities for butyramide as substrate. The substrate profiles of the 12 PhB group of mutants (PAC375 to ~~~3 8 7 ) were almost identical and only PAC377 has been listed; similarly the values for the three PhF group (~~~3 9 2 to PAC394) were identical and only PAC392 is listed. The parent strains producing B amidase (PAC351) and V amidase (PAC360) are shown in the same way but the constitutive mutant P A C I~~ (CB4) producing wild-type A amidase is omitted. The specific activity for butyramide hydrolysis of an overnight culture of strair, CB4 grown in pyruvate medium was 0.3. The ratio for butyramide to acetamide hydrolysis rates for the wild-type A amidase is 100:5000. The A amidase has negligible activity for valeramide and no hydrolysis of phenylacetamide could be detected. The washed suspensions of the Ph mutants hydrolysed all the amides tested with the exception of formamide, and in some cases acetamide. The specific activities are much lower than those of the A and B amidases for their optimal substrates. The Ph mutants thus appear to have gained an increase in the substrate range of the amidase at the expense of a decrease in the specific activity of the enzyme. For butyramide as substrate, the specific activities range from 10 to 100% of that of the B amidase but for valeramide, all the Ph mutants have specific activities which are the same or higher than most of the v mutants which were isolated on valeramide. There appear to be two phenotypic groups: group I, the acetamidenegative strains, which includes the PhB mutants (PAC375 to ~~~3 8 7 )
and PhvI (~~~3 8 8 ) ; group 11, the mutants with weak acetamide activity (25% of the butyramide rate) which includes Phvz (PAC398), PhAI (PAC39I) and the PhF mutants (~~~3 9 2 to ~~~3 9 4 ) . The group I mutants had lower specific activities on all the substrate amides than did the group I1 mutants.
The relative transferase assays for the amidases produced by the Ph mutants gave results which were essentially similar to those obtained for hydrolase activity ( The transferase assay was linear with the period of incubation for at least 30 min with all amides except propionamide for which the reaction appeared to be subject to marked substrate (or product) inhibition. This effect was more pronounced with the Ph group of mutants than with any of the other types of mutants, although substrate inhibition by acetamide and propionamide at high amide concentrations had been observed previously for the A and B amidases (Brown, 1969) . Substrate inhibition by propionamide did not occur in the hydrolase reaction so that propion hydroxamate may have been responsible.
A concentration of 0.2 M was used for the aliphatic amides for both hydrolase and transferase assays with all mutants. Later determinations with pure enzymes showed that this was not saturating for butyramide for the PhB and PhVr amidases but was sufficient to saturate the PhFr amidase (Table 6 ). If saturating concentrations of butyramide had been used it is possible that the relative specific activities for butyramide would have appeared somewhat higher. Phenylacetamide is relatively insoluble in water and the maximum concentration which could be achieved was 0.05 M but this proved to be sufficient to saurate all the Ph enzymes.
Amidase acfirities of extracts of organisms The results obtained with washed suspensions could have reflected differences in permeability to the various amides. Brarnmar, McFarlane & Clarke (1966) had shown that the wild-type strain had a constitutive permease which enabled it to take up and concentrate acetamide and N-acetylacetamide. The permeability of the bacteria to other amides has not been rigorously tested, and it is not known whether the same permease is responsible for the uptake of the other amides. However, examination of the B group of mutants showed that the extracts had the same amide substrate profile as the intact bacteria. The Ph group of mutants differed considerably from the wild-type strain in substrate specificity, and the relative arnide transferase and hydrolase rates of extracts of the mutants 
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I were compared with those previously obtained for whole organisms. There were no significant differences in the substrate profiles obtained, so that the relative values for extracts were similar to those given for whole organisms in Tables 3 and 4 . Amides which had not been substrates of the whole organisms were not attacked by extracts. In no case was the specific activity, calculated as pmol butyramide hydrolysed/mg proteinlmin, greater for extracts than for whole bacteria. In spite of the differences in the sizes of the amide molecules it did not appear that permeability was the rate determining step for amide utilization by any of the strains. These results could not completely rule out permeability limitations since breakage of the organisms could have caused some inactivation of the enzymes.
Substrate range of amidases from phenylacetamide mutants Partially purified amidase preparations from strains PhB, PhvI, PhAI and PhFr were tested on a wider range of amides for transferase activity. Table 5 summarizes these results and compares the amidases produced by the group I Ph mutants, which lack activity on acetamide, with the B enzyme from strain PAC351, with the rate for butyramide set at 100. The amidases produced by group I1 Ph mutants which have some activity towards acetamide are compared with the A amidase from strain P A C I~~ with the acetamide rate set at roo. In addition to the aliphatic amides listed in Table 4 the extracts were tested on isobutyramide, isovaleramide and hexanoamide. All of these amides were substrates for the Ph amidases with hexanoamide being one of the best substrates. The branched chain amides were less effective as substrates than were the corresponding strain chain compounds for both the Ph and B amidases. Benzamide was not hydrolysed to a significant extent by any of the enzymes although slight activity was detected with PhFr . Mandelamide was a substrate for the three Ph amidases tested but the activity was very low. Phenylpropionamide was a better substrate than phenylacetamide especially for the group I enzymes.
Physico-chemical properties of Plz amidases
Comparison of A, B and A1 amidases by starch-gel electrophoresis had shown that they differed from one another in electrophoretic mobility. The regulator phenotype of the strains producing these enzymes was such that the amidase constituted 5 % or more of the total bacterial protein and appeared as the major protein band even in crude extracts. All the Ph mutants had been derived from parent strains with similar magno-constitutive regulatory mutations. It was possible, however, that the low specific activities of intact suspensions and crude extracts were due not only to mutations in the amidase structural gene but also to mutations in the regulator gene resulting in decreased amounts of amidase proteins. The overall protein pattern obtained with extracts of all the Ph mutants was similar to that of the parental type with a heavy protein band at the amidase position. However, no amidase activity could be detected at this position by the transferase reaction or hydrolase Phenylacetamide-utiliziug mutants of P. aeruginosa reactions. It seemed likely that the heavy band was that of the amidase protein and that the lack of reaction with the amide reagents was due to the very low specific activity of the mutant enzymes and to possible inactivation during the electrophoresis.
The A and B amidases are stable to heating at 60 "C for ro niin but the acetanilideamidase produced by mutant ~~~3 6 6 (~1 3 ) loses about 50u/; of its activity during this treatment (Brown &Clarke, 1972) . Extracts of the Ph mutants were tested for thermal stability and gave the results shown in Fig. I . Amidases from Ph group I, the PhB mutants and Phvi, were relatively thermostable and retained over So(;; of their activity after 10 min. This was particularly interesting since mutant Phv I had been obtained by an additional mutation in the structural gene of strain ~~~3 6 0 (v9) which has an unstable amidase. Mutants of Ph group I1 produced thermolabile amidases. The half-life of the enzymes at 60 "C was 0.5 min for PhAi and 2-5 to 3 min for the enzymes from PhFr and Phv2. This thermal lability of the enzymes was confirmed with a purified preparation of the PhFr amidase.
The amidases produced by the Ph group 1 I mutants were also unstable at low temperatures.
Extracts stored at 4 "C lost all activity in a few days but the addition of 576 (v/v) giycerol together with dithiothreitol ( I mM) to the crude extract more than tripled the half-life of the enzymes. Extracts containing A, B or Ph group I amidases (PhB and PhvI) could be stored Fig. 2 . Immunodiffusion reactions in agar gels. The centre well contains antiserum to purified A amidase. The outside wells contain pure preparations of A and B amidases and crude extracts of P h~j and PhFr.
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at 4 "C for several months with very little loss of activity. Group I1 Ph amidases lost activity very rapidly if frozen and thawed, whereas the A, B and PhB amidases retained almost all their original activity after this treatment. Extracts and partially purified preparations were tested for immunodiffusion crossreactions with antisera prepared against A and B amidases. All the Ph amidases gave complete cross-reactions but in addition to the major band which indicated complete antigenic homology with A and B amidases there were fainter precipitin lines which appeared to the inside of the major band as shown in Fig. 2 . Extracts which had been stored for some time and had lost amidase activity gave only the inner precipitin lines which might represent a dissociated form of the enzyme.
Comparison of kinetic constants
Apparent Michaelis constants were determined with amidase preparations containing at least 6074 pure enzyme from the phenylacetamide mutants P h~3 , PhvI, PhFI (PAC377, ~~~3 8 8 and PAC392) and ~6 (PAC351). Fig. 3 gives the Lineweaver-Burk plots for PhFI, PhvI and ~6 with butyramide and Fig. 4 for PhFI, Phvr and P h~3 with phenylacetamide. The specific activities of these enzymes have not been accurately determined since they tend to lose activity on storage. It was therefore not possible to make valid calculations for Vma, from these data. However, comparison of the specific activities of the enzymes during purification confirmed the observations made with whole organisms and extracts that the amidases produced by the phenylacetamide mutants are much less active on their best substrates, e.g. valeramide, than are the A and B enzymes on their best substrates, e.g. acetamide and propionamide. The apparent K, values for the enzymes produced by P h~3 and PhvI are higher for butyramide than that previously measured for the B amidase but the enzyme Phenylacetamide-utilizing mutants of P. aeruginosa 
D I S C U S S I O N
Phenylacetamide-utilizing strains of Pseudornonas aeruginosa were evolved from the acetamide-utilizing wild-type and there was not a unique mutational pathway for the successive changes in the genes concerned. Fig. 5 outlines the steps by which the five individually distinct phenylacetamide mutants were obtained; all the others isolated belonged to one or another of these classes. All the Ph mutants are constitutive and have a mutation in the amidase regulator gene, amiR. Only PAC392 (PhFr) was derived by a single mutation in the structural gene and is therefore likely to differ from the wild-type by a single amino acid change. ~~~3 7 7 (Phs3) and PAC391 ( P h A i ) must have have two mutations, although these could have been in the same codon on each occasion and do not necessarily involve changes in two amino acids. The Phv mutants, ~~~3 8 8 and ~~~3 8 9 , must have had three mutational changes but again this need not mean changes in three separate amino acids in the protein chain. It was particularly interesting that two different amidases were obtained by spontaneous mutation of the amidase structural gene of strain ~~~3 6 0 (v9). The Phvr and Phv2 proteins differed both in substrate profile and thermal stability and must therefore have had quite different amino acid substitutions.
Whereas the amidase produced by the parent strain ~~~3 6 0 (v9) was very unstable in extracts, the enzymes produced by both PhvI and Phv2 were stable enough for their properties to be investigated, although the Phvz amidase was thermolabile. In a certain sense the additional mutations in the two strains derived from vg could be considered to be internal suppressor mutations allowing the production of more stable enzymes. As far as activity with valeramide as a substrate is concerned, both the mutations have resulted in amidases with higher specific activities for valeramide hydrolysis. We observed previously that some of the mutants isolated on valeramide plates, after mutagenesis of the butyramideutilizing strain PAC35 I , had higher specific activities for butyramide hydrolysis than the parent strain which had been isolated on butyramide medium. This suggested that if mutant strains were required to attack a specific amide it might be advantageous to select for them on a medium containing an amide with a larger side-chain than the required substrate. We have confirmed this finding with the present series of mutants. Valeramide and hexoanoamide are the optimum substrates for all the phenylacetamide group of mutants. The mutants we have described represent five possible lines of evolution of phenylacetamide-utilizing strains. However, these strains are all constitutive and in nature such enzymes are usually inducible. It is possible that a further mutation in the amidase regulator gene could lead to an inducible phenylacetamide-utilizing strain. We have previously shown that the regulator gene product may respond in different ways to amide inducers and inducer analogues. The wild-type strain, and such constitutive mutants as PACIII, are subject to amide analogue repression by butyramide, while other constitutive mutants like PACI 28 are Phenylacetumide-utiliziq mutants of P. aeruginosa I73 resistant and grow on butyramide. A mutation in the regulator gene which led to butyramideinducibility would also allow growth on butyramide but this type of mutation has not been encountered among the Pseudomonas aeruginosa mutants which have been isolated so far.
However, P. putida and P. acidovorans grown on acetamide and butyramide and the enzyme is induced by both amides (Clarke, 1972) . Mutations leading to alterations in inducer specificity can occur in P. aeruginosa, and Brammar et al. (1967) isolated mutants with an increased rate of induction by formamide, which grew on succinate + formamide medium.
This series of phenylacetamide mutants does not necessarily represent the end of possible evolution of a phenylacetamide-utilizing phenotype. It might be an advantage for a strain to acquire further regulator mutations to enable phenylacetamide to act as an inducer, and it might also be a selective advantage to introduce further mutations in the structuralgene which would increase the specific activity of the amidases, and, in the case of group I1 mutants, to increase the enzyme stability. Although all five of the different phenylacetamide mutants grew equally well under the laboratory conditions under which they were tested, it may well be that under the more competitive situation of utilizing phenylacetamide in the natural environment some differences would be apparent. If any one of the mutants could outgrow the others it might then undergo some further mutations and eventually reach a stable genotype and fill an ecological niche not available to the original wild-type strain.
Stephenson (r949) commented that bacterial evolution was still continuing and suggested that biochemical evolution in bacteria could be controlled and imitated in the laboratory. Attempts have been made by several workers to analyse the mutational changes occurring during the acquisition of new metabolic pathways. Hegeman & Rosenberg (1970) pointed out that this is frequently achieved by a regulatory mutation. If' a compound is a substrate for an enzyme already present in the organism, but not an inducer of the enzyme, then a mutation to constitutivity may allow growth to occur. This type of mutation in Pseudomonas aerugitzosa produced the regulatory mutants of the CB series which were able to grow on butyramide. Mortlock, Fossitt & Wood (1965) had previously shown that mutations in Aerobacter aerogenes which allowed growth on certain alcohols and sugars, not utilized by the parent strains, involved constitutive enzyme synthesis. In some cases constitutive synthesis of specific permeases may also enable growth to occur on new substrates. Wu, Lin & Tanaka (1967) described a series of mutations in A . aerogenes which produced mutants able to grow on xylitol. This is a substrate for ribitol dehydrogenase, but not an inducer, and the first mutation resulted in constitutive synthesis of ribitol dehydrogenase. A second mutation resulted in a ribitol dehydrogenase with a higher affinity for xylitol and this mutant therefore carried both a regulator and structural gene mutation and was analogous to the constitutive P. aerugiriosa mutants producing altered enzymes. A third mutafion in A . aerogenes resulted in the constitutive synthesis of an arabitol permease which is also able to transport xylitol into the cell and this mutant was able to grow on xylitol at a faster rate than the two earlier mutants .
If strains of bacteria are required to carry out particular metabolic reactions it may be possible to improve on the naturally occurring species by selecting for regulatory mutations allowing constitutive synthesis of enzymes (or permeases) which already possess weak affinities for the required substrates. Successive selection under conditions where these substrates are essential for growth might then allow the selection of new strains producing mutant enzymes and then strains which could be induced by the new growth substrates. The metabolic pathways for the degradation of biological compounds have evolved over millenia but it is possible that new pathways for the degradation of unwanted and persistent chemicals could arise by the application of these principles of directed evolution.
